Castlelake, L.P. on the formation and fundraising of Castlelake Aviation V Stable Yield, L.P. and certain related aviation strategy investment vehicles, accounts and co-investments.
The Carlyle Group on the final closing of its fifth Japan-focused private equity fund, Carlyle Japan Partners V.
Hildred Capital backed-Crown Laboratories in its proposed $924 million acquisition of and subsequent $325 million amended merger agreement to acquire Revance Therapeutics.
Hildred Capital on the final closing of Hildred Equity Partners III.
